Atlas Trials

Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency

Clinical trial NCT02019667 · COMPLETED

Trial details

NCT number
NCT02019667
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metabolic DiseaseSeizures
Start date
2014-03-31
Primary completion
2019-01-31
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.